{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:42:57Z","timestamp":1793828577344,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2024142"],"award-info":[{"award-number":["A2024142"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03115-1","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T06:16:03Z","timestamp":1771740963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between estimated glucose disposal rate and cause-specific mortality among individuals with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Wenguang","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"issue":"4","key":"3115_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"issue":"7","key":"3115_CR2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999-2014.e1.","journal-title":"Gastroenterology"},{"issue":"9","key":"3115_CR3","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","volume":"107","author":"KE Chan","year":"2022","unstructured":"Chan KE, Koh TJL, Tang ASP, Quek J, Yong JN, Tay P, et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107(9):2691\u2013700.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3115_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-025-02824-3","volume":"24","author":"E Han","year":"2025","unstructured":"Han E, Han KD, Lee YH, Kim KS, Hong S, Park JH, et al. Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality. Cardiovasc Diabetol. 2025;24(1):289.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3115_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14218\/JCTH.2021.00178","volume":"10","author":"E Kaya","year":"2022","unstructured":"Kaya E, Yilmaz Y. Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver. J Clin Transl Hepatol. 2022;10(2):329\u201338.","journal-title":"J Clin Transl Hepatol"},{"key":"3115_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/nu15051123","author":"T Tsutsumi","year":"2023","unstructured":"Tsutsumi T, Nakano D, Hashida R, Sano T, Kawaguchi M, Amano K, et al. The inter-organ crosstalk reveals an inevitable link between MAFLD and extrahepatic diseases. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15051123.","journal-title":"Nutrients"},{"issue":"3","key":"3115_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","volume":"73","author":"HH Lee","year":"2024","unstructured":"Lee HH, Lee HA, Kim EJ, Kim HY, Kim HC, Ahn SH, et al. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut. 2024;73(3):533\u201340.","journal-title":"Gut"},{"issue":"2","key":"3115_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101182","volume":"29","author":"ADC Maldonado-Rojas","year":"2024","unstructured":"Maldonado-Rojas ADC, Zuarth-V\u00e1zquez JM, Uribe M, Barbero-Becerra VJ. Insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD): pathways of action of hypoglycemic agents. Ann Hepatol. 2024;29(2):101182.","journal-title":"Ann Hepatol"},{"issue":"1","key":"3115_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57\u201363.","journal-title":"Diabetes Care"},{"issue":"4","key":"3115_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/17843286.2022.2160889","volume":"78","author":"JR Delanghe","year":"2023","unstructured":"Delanghe JR, Verlinde E, Speeckaert MM, Maenhout T. HOMA-IR and HOMA2-IR estimation based on glycated hemoglobin as an alternative for fasting glucose. Acta Clin Belg. 2023;78(4):308\u201312.","journal-title":"Acta Clin Belg"},{"issue":"1","key":"3115_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02396-8","volume":"23","author":"HM He","year":"2024","unstructured":"He HM, Xie YY, Chen Q, Li YK, Li XX, Mu YK, et al. The additive effect of the triglyceride-glucose index and estimated glucose disposal rate on long-term mortality among individuals with and without diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):307.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3115_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-024-02570-y","volume":"24","author":"J Liao","year":"2025","unstructured":"Liao J, Wang L, Duan L, Gong F, Zhu H, Pan H, et al. Association between estimated glucose disposal rate and cardiovascular diseases in patients with diabetes or prediabetes: a cross-sectional study. Cardiovasc Diabetol. 2025;24(1):13.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3115_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-025-02575-1","volume":"24","author":"J Zhang","year":"2025","unstructured":"Zhang J, Sun Z, Li Y, Yang Y, Liu W, Huang M, et al. Association between the cumulative estimated glucose disposal rate and incident cardiovascular disease in individuals over the age of 50 years and without diabetes: data from two large cohorts in China and the United States. Cardiovasc Diabetol. 2025;24(1):51.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3115_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-025-02729-1","volume":"24","author":"B Dong","year":"2025","unstructured":"Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0\u20133 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):163.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3115_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70524","volume":"31","author":"T Wang","year":"2025","unstructured":"Wang T, Jiang H, Zheng R, Zhang C, Ma X, Liu Y. Assessing the impact of estimated glucose disposal rate (eGDR) on cognitive function in older adults: a NHANES-based machine learning study. CNS Neurosci Ther. 2025;31(7):e70524.","journal-title":"CNS Neurosci Ther"},{"key":"3115_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1621074","volume":"12","author":"D Liu","year":"2025","unstructured":"Liu D, Lv X, Li W, Dai H, Tan Y, Yang D, et al. Association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and dyslipidemia in US adults: a cross-sectional study. Front Nutr. 2025;12:1621074.","journal-title":"Front Nutr"},{"key":"3115_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1579879","volume":"12","author":"W Peng","year":"2025","unstructured":"Peng W, Li Z, Fu N. Association between eGDR and MASLD and liver fibrosis: a cross-sectional study based on NHANES 2017-2023. Front Med. 2025;12:1579879.","journal-title":"Front Med"},{"issue":"1","key":"3115_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12902-025-01891-7","volume":"25","author":"W Liu","year":"2025","unstructured":"Liu W, Li X, Chen L, Luo X. The association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in US adults. BMC Endocr Disord. 2025;25(1):67.","journal-title":"BMC Endocr Disord"},{"key":"3115_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1589245","volume":"12","author":"Y Li","year":"2025","unstructured":"Li Y, Ye X, Chen X. Association of estimated glucose disposal rate with risk of future metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases: a prospective cohort study. Front Med. 2025;12:1589245.","journal-title":"Front Med"},{"key":"3115_CR20","doi-asserted-by":"crossref","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology (Baltimore, Md). 2007;46(1):32\u20136.","DOI":"10.1002\/hep.21669"},{"issue":"6","key":"3115_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology (Baltimore, MD). 2023;78(6):1966\u201386.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"10","key":"3115_CR22","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.2337\/dc20-0433","volume":"43","author":"M Garofolo","year":"2020","unstructured":"Garofolo M, Gualdani E, Scarale MG, Bianchi C, Aragona M, Campi F, et al. Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study. Diabetes Care. 2020;43(10):e139\u201341.","journal-title":"Diabetes Care"},{"issue":"1","key":"3115_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-021-01394-4","volume":"20","author":"A Zabala","year":"2021","unstructured":"Zabala A, Darsalia V, Lind M, Svensson AM, Franz\u00e9n S, Eliasson B, et al. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2021;20(1):202.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3115_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12933-025-02705-9","volume":"24","author":"D Denimal","year":"2025","unstructured":"Denimal D, Ponnaiah M, Phan F, Jeannin AC, Redheuil A, Salem JE, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2025;24(1):176.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3115_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24(1):52.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3115_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3115_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"key":"3115_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1398265","volume":"15","author":"J Song","year":"2024","unstructured":"Song J, Ma R, Yin L. Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease. Front Endocrinol. 2024;15:1398265.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3115_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12876-025-03798-y","volume":"25","author":"XC Tong","year":"2025","unstructured":"Tong XC, Liu K, Xu JY, Zhang XJ, Xue Y. A negative correlation of low estimated glucose disposal rate with significant liver fibrosis in adults with NAFLD and obesity: results from NHANES 2017-2020. BMC Gastroenterol. 2025;25(1):206.","journal-title":"BMC Gastroenterol"},{"key":"3115_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109827","volume":"186","author":"M de Vries","year":"2022","unstructured":"de Vries M, Westerink J, El-Morabit F, Kaasjager H, de Valk HW. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes. Diabetes Res Clin Pract. 2022;186:109827.","journal-title":"Diabetes Res Clin Pract"},{"key":"3115_CR31","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.15.04249","volume":"15","author":"X Chen","year":"2025","unstructured":"Chen X, Du L, Peng J. Association between estimated glucose disposal rate and cardiovascular disease prevalence and mortality outcomes in metabolic dysfunction-associated steatotic liver disease: a comparative analysis of insulin resistance markers. J Glob Health. 2025;15:04249.","journal-title":"J Glob Health"},{"issue":"11","key":"3115_CR32","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/cimb45110570","volume":"45","author":"M Veskovi\u0107","year":"2023","unstructured":"Veskovi\u0107 M, \u0160utulovi\u0107 N, Hrn\u010di\u0107 D, Stanojlovi\u0107 O, Macut D, Mladenovi\u0107 D. The interconnection between hepatic insulin resistance and metabolic dysfunction-associated steatotic liver disease-the transition from an adipocentric to liver-centric approach. Curr Issues Mol Biol. 2023;45(11):9084\u2013102.","journal-title":"Curr Issues Mol Biol"},{"issue":"Suppl 3","key":"3115_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","volume":"32","author":"G Boden","year":"2002","unstructured":"Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002;32(Suppl 3):14\u201323.","journal-title":"Eur J Clin Invest"},{"key":"3115_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1244405","volume":"14","author":"G Semmler","year":"2023","unstructured":"Semmler G, Balcar L, Wernly S, V\u00f6lkerer A, Semmler L, Hauptmann L, et al. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease. Front Endocrinol. 2023;14:1244405.","journal-title":"Front Endocrinol"},{"issue":"4","key":"3115_CR35","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/hep.29926","volume":"68","author":"F Zhang","year":"2018","unstructured":"Zhang F, Hu Z, Li G, Huo S, Ma F, Cui A, et al. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice. Hepatology (Baltimore, MD). 2018;68(4):1361\u201375.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"3115_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","volume":"7","author":"D Santoleri","year":"2019","unstructured":"Santoleri D, Titchenell PM. Resolving the paradox of hepatic insulin resistance. Cell Mol Gastroenterol Hepatol. 2019;7(2):447\u201356.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3115_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133649","author":"R Palma","year":"2022","unstructured":"Palma R, Pronio A, Romeo M, Scognamiglio F, Ventriglia L, Ormando VM, et al. The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11133649.","journal-title":"J Clin Med"},{"issue":"9","key":"3115_CR38","volume":"15","author":"P Abha","year":"2023","unstructured":"Abha P, Keshari JR, Sinha SR, Nishant K, Kumari R, Prakash P. Association of thyroid function with lipid profile in patients with metabolic syndrome: a prospective cross-sectional study in the Indian population. Cureus. 2023;15(9):e44745.","journal-title":"Cureus"},{"issue":"9468","key":"3115_CR39","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet (London, England). 2005;365(9468):1415\u201328.","journal-title":"Lancet (London, England)"},{"key":"3115_CR40","doi-asserted-by":"publisher","first-page":"1500993","DOI":"10.3389\/fendo.2025.1500993","volume":"16","author":"X Huang","year":"2025","unstructured":"Huang X, He S, Wang C, Jian G, Jiang K, Lu Z, et al. Association between estimated glucose disposal rate and prediabetes reversion and progression: a nationwide cohort study of middle-aged and elderly people in China. Front Endocrinol. 2025;16:1500993.","journal-title":"Front Endocrinol"},{"key":"3115_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu15112513","author":"K Szewczyk-Golec","year":"2023","unstructured":"Szewczyk-Golec K, Ho\u0142y\u0144ska-Iwan I. Dietary interventions in obesity and metabolic syndrome. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15112513.","journal-title":"Nutrients"},{"issue":"6","key":"3115_CR42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2020.05.026","volume":"19","author":"J Fritsch","year":"2021","unstructured":"Fritsch J, Garces L, Quintero MA, Pignac-Kobinger J, Santander AM, Fern\u00e1ndez I, et al. Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis. Clinical gastroenterology and hepatology\u202f: the official clinical practice journal of the American Gastroenterological Association. 2021;19(6):1189-99.e30.","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03115-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03115-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03115-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:29:07Z","timestamp":1774618147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03115-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3115"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03115-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,22]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent has been obtained from every participant and therefore there was no need for any ethical consent in this study. The NCHS ethics review board has approved the NHANES protocol. All procedures were performed in accordance with the relevant guidelines and regulations","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}